Lupus, An Issue of Rheumatic Disease Clinics of North America, 1st Edition
Author :
Edited by Zahi Touma, MD, PhD and Alfred Kim
This issue of Rheumatic Disease Clinics, guest edited by Dr. Alfred Kim and Zahi Touma, will discuss a number of key topics surrounding Lupus. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discu
...view more
This issue of Rheumatic Disease Clinics, guest edited by Dr. Alfred Kim and Zahi Touma, will discuss a number of key topics surrounding Lupus. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Interferons in SLE, NETosis and neutrophils in SLE, AMP update in lupus nephritis, Patient-reported outcomes, Complement, T cells in SLE, B cells in SLE, Outcome measures for SLE clinical trials, Mitochondrial physiology in SLE, Pregnancy, Lupus cohorts, Innovative trials and new opportunities in SLE, Classification and diagnosis of SLE, and Updates on SLE Treatment.
This issue of Rheumatic Disease Clinics, guest edited by Dr. Alfred Kim and Zahi Touma, will discuss a number of key topics surrounding Lupus. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Interferons in SLE, NETosis and neutrophils in SLE, AMP update in lupus nephritis, Patient-reported outcomes, Complement, T cells in SLE, B cells in SLE, Outcome measures for SLE clinical trials, Mitochondrial physiology in SLE, Pregnancy, Lupus cohorts, Innovative trials and new opportunities in SLE, Classification and diagnosis of SLE, and Updates on SLE Treatment.
Author Information
Edited by Zahi Touma, MD, PhD, Assistant Professor of Medicine, University of Toronto; Clinician Scientist, Krembil Research Institute
Toronto, Ontario, Canada and Alfred Kim
Edited by Zahi Touma, MD, PhD, Assistant Professor of Medicine, University of Toronto; Clinician Scientist, Krembil Research Institute
Toronto, Ontario, Canada and Alfred Kim
Interferons in Systemic Lupus Erythematosus Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus The Power of Systems Biology: Insights on Lupus Nephritis from the Accelerating Medicines Partnership Patient-Reported Outcomes in Lupus T Cells in Systemic Lupus Erythematosus B Cells in Systemic Lupus Erythematosus: From Disease Mechanisms to Targeted Therapies Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus Management of Pregnancy in Lupus Lupus Cohorts Innovative Trials and New Opportunities in SLE Systemic Lupus Erythematosus Classification and Diagnosis Treatment Update in Systemic Lupus Erythematous
https://www.elsevierhealth.com.au/lupus-an-issue-of-rheumatic-disease-clinics-of-north-america-9780323835565.html297724Lupus, An Issue of Rheumatic Disease Clinics of North Americahttps://www.elsevierhealth.com.au/media/catalog/product/9/7/9780323835565_105.jpg168.72224.95AUDInStock/Medicine & Surgery/Rheumatology/Clinics/Medicine/Rheumatology/Clinics/Clinics/Medicine/Rheumatology/Japan Titles4335090438872550545555054666525504152598355263160This issue of Rheumatic Disease Clinics, guest edited by Dr. Alfred Kim and Zahi Touma, will discuss a number of key topics surrounding Lupus. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Interferons in SLE, NETosis and neutrophils in SLE, AMP update in lupus nephritis, Patient-reported outcomes, Complement, T cells in SLE, B cells in SLE, Outcome measures for SLE clinical trials, Mitochondrial physiology in SLE, Pregnancy, Lupus cohorts, Innovative trials and new opportunities in SLE, Classification and diagnosis of SLE, and Updates on SLE Treatment. This issue of Rheumatic Disease Clinics, guest edited by Dr. Alfred Kim and Zahi Touma, will discuss a number of key topics surrounding Lupus. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Interferons in SLE, NETosis and neutrophils in SLE, AMP update in lupus nephritis, Patient-reported outcomes, Complement, T cells in SLE, B cells in SLE, Outcome measures for SLE clinical trials, Mitochondrial physiology in SLE, Pregnancy, Lupus cohorts, Innovative trials and new opportunities in SLE, Classification and diagnosis of SLE, and Updates on SLE Treatment. 00add-to-cart97803238355652021ProfessionalEdited by Zahi Touma, MD, PhD and Alfred Kim20211Book152w x 229hElsevier24015 July 2021Please allow 7-10 working days for deliveryEdited by <STRONG>Zahi Touma</STRONG>, MD, PhD, Assistant Professor of Medicine, University of Toronto; Clinician Scientist, Krembil Research Institute
Toronto, Ontario, Canada and <STRONG>Alfred Kim</STRONG>ClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
